Abstract
Meningiomas are the most common primary tumors of the central nervous system and as such they are often encountered at neuroimaging. Fortunately, meningiomas are readily diagnosed with anatomic computed tomography and magnetic resonance imaging. While conventional imaging is the mainstay for initial diagnosis and delineating tumor for treatment planning and posttreatment follow-up, the last couple of decades have given rise to advanced physiologic and metabolic imaging techniques that serve as powerful tools in the management of meningioma. These modern approaches are allowing imaging to expand its utility to include extraction of biologic and potentially prognostic information that will ultimately improve care for meningioma patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
